Grünenthal Overview

  • Year Founded
  • 1946

Year Founded

  • Status
  • Private

  • Employees
  • 4,400

Employees

  • Latest Deal Type
  • Debt Refin.

  • Financing Rounds
  • 10

  • Investments
  • 20

Grünenthal General Information

Description

Operator of a pharmaceutical company intended to serve clients across Germany. The company invests in research and development to treat unmet medical needs and bring products to markets that aid in pain treatment and management, thereby enabling clients with effective and life-changing medicines.

Contact Information

Website
www.grunenthal.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Zieglerstraße 6
  • 52078 Aachen
  • Germany
+49 0241 0000
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Other Healthcare Services
Corporate Office
  • Zieglerstraße 6
  • 52078 Aachen
  • Germany
+49 0241 0000

Grünenthal Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Grünenthal Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Grünenthal‘s full profile, request access.

Request a free trial

Grünenthal Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pharmaceutical company intended to serve clients across Germany. The company invests in research and devel
Pharmaceuticals
Aachen, Germany
4,400 As of 2023
00.000
000000000 00 00.000

0000 0

at. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore
000000000000000
Monmouth Junction, NJ
000 As of 0000
000000000 -

000000

m veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commod
0000000000000 000000
Laval, Canada
00 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Grünenthal Competitors (19)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tris Pharma Private Debt Financed Monmouth Junction, NJ 000 000000000 -
Corealis Pharma Private Equity-Backed Laval, Canada 00 000000000000
Sanofi Corporation Paris, France 00000 00.00 000000000 00.00
US WorldMeds Venture Capital-Backed Louisville, KY 00 0000000000
Acorda Therapeutics Corporate Backed or Acquired Ardsley, NY 000 00000 000000&0
You’re viewing 5 of 19 competitors. Get the full list »

Grünenthal Patents

  • 5,244

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1,921

    Granted

  • 194

    Pending

  • 000

    Expiring in next 12 mo

Grünenthal Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4385979-A1 Multicyclic inhibitors of nav1.8 Inactive 14-Dec-2022 0000000000 0
EP-4385984-A1 Pyridine-n-oxides as inhibitors of nav1.8 Inactive 14-Dec-2022 0000000000 0
EP-4385980-A1 Indazoles as inhibitors of nav1.8 Inactive 14-Dec-2022 0000000000 0
US-20240252473-A1 Sulfoximines as inhibitors of nav1.8 Inactive 14-Dec-2022 000000000
US-20230025025-A1 Substituted pyrazole amides Active 15-Jun-2021 C07D231/14
To view Grünenthal’s complete patent history, request access »

Grünenthal Executive Team (11)

Name Title Board Seat
Gabriel Baertschi Chairman of the Corporate Executive Board & Chief Executive Officer
Fabian Raschke Chief Financial Officer & Member of the Corporate Executive Board
Jan Adams MD Chief Scientific Officer & Member of the Corporate Executive Board
Janneke Kamp Chief Commercial Officer & Member of the Corporate Executive Board
Ulrike Albus Senior Counsel, Patents and Trademarks, European Patent Attorney & German Patent Attorney
You’re viewing 5 of 11 executive team members. Get the full list »

Grünenthal Board Members (7)

Name Representing Role Since
000000 0000000 Grünenthal Chief Financial Officer & Member of the Corporate Executive Board 000 0000
0000000 000000000 Grünenthal Chairman of the Corporate Executive Board & Chief Executive Officer 000 0000
000 00000 00 Grünenthal Chief Scientific Officer & Member of the Corporate Executive Board 000 0000
0000000 0000 Grünenthal Chief Commercial Officer & Member of the Corporate Executive Board 000 0000
You’re viewing 4 of 7 board members. Get the full list »

Grünenthal Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Grünenthal Investments & Acquisitions (20)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Valinor Pharma 22-Jul-2024 0000000000 00000 Pharmaceuticals 0000000 0
Fern Health 01-Dec-2023 0000000000 Clinics/Outpatient Services
Grünenthal Meds 02-Aug-2023 00000 0000 Other Pharmaceuticals and Biotechnology 000000 00
NebidoTM 02-Nov-2022 000000000 00000 Buildings and Property 0000000 0
Mestex Pharmaceutical 12-Apr-2021 Merger/Acquisition Biotechnology 0000000 0
You’re viewing 5 of 20 investments and acquisitions. Get the full list »

Grünenthal Subsidiaries (7)

Company Name Industry Location Founded
Adhesys Medical Biotechnology Aachen, Germany 2013
Grunenthal Denmark Distributors/Wholesale Copenhagen, Denmark 0000
Grunenthal Distributors/Wholesale Maidenhead, United Kingdom 0000
Grünenthal B.V. Distributors/Wholesale Breukelen, Netherlands 0000
Laboratoires Grunenthal Distributors/Wholesale Puteaux, France 0000
You’re viewing 5 of 7 subsidiaries. Get the full list »

Grünenthal FAQs

  • When was Grünenthal founded?

    Grünenthal was founded in 1946.

  • Who is the CEO of Grünenthal?

    Gabriel Baertschi is the CEO of Grünenthal.

  • Where is Grünenthal headquartered?

    Grünenthal is headquartered in Aachen, Germany.

  • What is the size of Grünenthal?

    Grünenthal has 4,400 total employees.

  • What industry is Grünenthal in?

    Grünenthal’s primary industry is Pharmaceuticals.

  • Is Grünenthal a private or public company?

    Grünenthal is a Private company.

  • What is Grünenthal’s current revenue?

    The current revenue for Grünenthal is 000000.

  • How much funding has Grünenthal raised over time?

    Grünenthal has raised $2.42B.

  • Who are Grünenthal’s competitors?

    Tris Pharma, Corealis Pharma, Sanofi, US WorldMeds, and Acorda Therapeutics are some of the 19 competitors of Grünenthal.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »